BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Cryptome Pharmaceuticals Pty. Ltd. Receives START Grant Approval For $3.9M Anti-Thrombotic Drug Development Project


10/19/2005 5:10:26 PM

Protein-focused drug discovery company, Cryptome Pharmaceuticals Ltd (ASX: CRP), announced today that development work on its lead drug candidate, the anti-coagulant CR001, will be boosted by a $1.95 million AusIndustry R&D START grant. The grant will fund up to 50 per cent of a $3.9 million project to test the efficacy and validate the safety of CR001, a naturally occurring peptide, as an effective alternative to current thrombosis drugs, all of which have shortcomings and some potentially life threatening side effects. The project, which is expected to be completed in early 2006, will include animal studies and other development activities up to and including application to the Therapeutic Goods Administration (TGA) for approval for a Phase I human clinical trial. Federal Industry Minister, Ian Macfarlane, today congratulated Cryptome Pharmaceuticals on being awarded the R&D Start grant and highlighted the project's tremendous potential return to Australia.



   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->